Insulet
PODD
#1895
Rank
C$15.44 B
Marketcap
C$222.99
Share price
-0.35%
Change (1 day)
-42.97%
Change (1 year)
Categories
Insulet Corporation is an American company that develops and sells medical devices used for the administration of insulin.

Earnings for Insulet (PODD)

Earnings in 2026 (TTM): C$0.64 Billion

According to Insulet's latest financial reports the company's current earnings are C$2.90 Billion. In 2025 the company made an earning of C$0.56 Billion, an increase over its 2024 earnings that were of C$0.48 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Insulet from 2006 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) C$0.64 B15.37%
2025 C$0.56 B16.3%
2024 C$0.48 B36.76%
2023 C$0.35 B481.9%
2022 C$60.68 M-45.24%
2021 C$0.11 B43.35%
2020 C$77.29 M18.51%
2019 C$65.22 M41.16%
2018 C$46.2 M-711.95%
2017 -C$7.56 Million-56.85%
2016 -C$17.51 Million-79.31%
2015 -C$84.6 Million63.85%
2014 -C$51.64 Million31.04%
2013 -C$39.41 Million-21.96%
2012 -C$50.5 Million
2010 -C$48.16 Million-42.38%
2009 -C$83.58 Million-33.56%
2008 -C$0.13 Billion65.93%
2007 -C$75.81 Million209.75%
2006 -C$24.48 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
C$36.57 B 5,436.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
C$11.45 B 1,634.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Medtronic
MDT
C$9.64 B 1,360.14%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Eli Lilly
LLY
C$43.82 B 6,533.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Tandem Diabetes Care
TNDM
-C$0.14 Billion-120.90%๐Ÿ‡บ๐Ÿ‡ธ USA
ICU Medical
ICUI
C$0.13 B-79.14%๐Ÿ‡บ๐Ÿ‡ธ USA
DexCom
DXCM
C$1.71 B 160.08%๐Ÿ‡บ๐Ÿ‡ธ USA